test

Nathan Fischel

@Dafna Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$423.312MTotal holdings84
Assets growth rate1.14%Assets growth rate (2-Q avg)-1.79%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Dafna Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 84 positions.

Assets under management

The assets under management (AUM) of Dafna Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 423.312M in assets, with a quarterly growth rate of 1.14% and a 2-quarter average growth rate of -1.79%. The portfolio is managed by Nathan Fischel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ACRVAcrivon Therapeutics Inc
Recent Activity
Decreased -7.36%
0.19%
$786,898
112,414 shares@ $7.0 avg price
SAGESage Therapeutics Inc
Recent Activity
Decreased -6.88%
0.19%
$781,204
108,200 shares@ $7.22 avg price
TRMLTourmaline Bio Inc
Recent Activity
Decreased -74.84%
0.12%
$491,318
19,110 shares@ $25.71 avg price
FHTXFoghorn Therapeutics Inc
Recent Activity
Decreased -10%
0.09%
$350,652
37,664 shares@ $9.32 avg price
NGNENeurogene Inc
Recent Activity
Decreased -29.31%
0.08%
$326,239
7,775 shares@ $41.96 avg price
ANROAlto Neuroscience Inc
Recent Activity
Decreased -77.67%
0.08%
$306,432
26,786 shares@ $11.45 avg price